The global skin antiseptic products market is expected to reach the market value of around US$ 318 Mn by 2026 and is anticipated to grow at a CAGR of around 6.7 % in terms of revenue during the forecast period 2019 – 2026.
The report provides analysis of global skin antiseptic products market for the period 2015-2026, wherein 2015-2017 is the historical year, 2019 to 2026 is the forecast period and 2018 is considered as the base year.
Human skin antiseptic medicines are used to defend themselves against germs or remove the microorganisms that already exist in their bodies. The infection control system is regarded as a vital component that keeps people or non-living things germ-free. The products are chemical agents, which slow or prevent the development of micro-organisms (germs) on external body surfaces. Skin disinfectants are often called antiseptics.
Product demand is rising due to higher prevalence of Hospital Acquired Infections (HAIs), lack of sanitation and precaution, and increased use of surgical units and endoscope reprocesses. Furthermore, the worldwide industry is experiencing comparatively greater development rates due to increase health care spending, elevated incidences of hospital-acquired infectious diseases, and increase knowledge of house cleanliness and disinfection need. Antiseptic skin is regarded vital parts of infection control. Skin antiseptic is used to maintain human or non-living germ-free. Antiseptic is a medicine used by people and livestock to prevent germs or eliminate current microorganisms in their bodies.
Skin antiseptic helps patients with different infections improve overall operational efficiency and patient care. High prevalence and incidence rates of acquired diseases in hospitals, increase focus on hygiene, and rise in concerns about the spread of infectious diseases in both residential and commercial / industrial spaces / healthcare units have resulted in increase patient flow to private clinics and hospitals. Collectively, these factors will increase demand for skin antiseptic products in the near future. Moreover, government efforts to reduce HAI cases and raise awareness of home and personal hygiene are projected to create growth opportunities for market players.
According to the Centers for Disease Control and Prevention (CDC), at least 1 in 25 hospital patients have one health-associated infection. This will boost skin antiseptic products demand. Antiseptic application usually offers security against contamination and reduces HAIs danger. Thus, such solutions are widely used in hospitals for proper hygiene and sanitation. These variables are anticipated to increase skin antiseptic product industry during the forecast period. Growing endoscopy use is also expected to increase HAIs risk. In such cases, skin antiseptic products solutions must be properly applied to prevent infection transmission.
North America dominates the global skin antiseptic products market in 2018 with revenue of around US$ 67 Mn and is likely to fuel during the forecast period. The increasing amount of surgeries conducted is one of the main factors favourably impacting market growth. Pre-operative skin preparation is one of the essential steps surgeons take before surgery. Thus, demand for skin-antiseptics products is expected to rise with the increasing rate of surgery. Increasing incidence of infectious diseases among the U.S. population is also a main contributor to market growth. Rise in practice of using branded skin antiseptic products has also been witnessed in U.S. healthcare units, which is projected to fuel U.S. market growth in the mid-term forecast.
Europe is projected to grow at a momentous CAGR of around 6.5% during the forecast timeframe. Increasing numbers of surgeries are likely to boost the usage frequency of antiseptic products. Furthermore, increase incidences of hospital-acquired infections, and improved per capita spending on healthcare are little value-added features that are expected to drive Europe skin antiseptic products market. Moreover, increasing numbers of hospitals in European economies have led to the global market significant share.
Asia Pacific skin antiseptic products industry is expected to grow rapidly over the forecast period. Increasing government and private sector healthcare spending is one of business drivers. Such scenario is expected to encourage several international and local companies to enter the regional market, increasing their growth. China dominated Asia Pacific skin antiseptic products market, while India market is estimated to expand at significant CAGR over the forecast period.
Latin America market is expected to grow considerably over the forecast period. Brazil and Mexico's region most advanced economy. Growing health education and chronic diseases will drive the national economy. Additionally, raising people knowledge of multiple illnesses and enhancing disposable income will also boost market growth in this region.
Middle East & Africa is driven by countries like South Africa & GCC. High expenditure capacity and request for advanced antiseptic item for healthcare and private use drive the industry. Due to the increasing economy in GCC countries like UAE & Kuwait, consumer development during the prediction era will also contribute significantly. High investments by Chinese companies in the region will boost development of better healthcare products like skin antiseptic, pushing the industry.
The market research study on “Skin Antiseptic Products Market (By Type: Swab Sticks, Solutions, Wipes; By Formulation: Iodine, Chlorhexidine, Octenidine, Alcohols, Others; By Application: Injections, Surgeries) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers a detailed insights on the global skin antiseptic products market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights on global skin antiseptic products market, its type, formulation, application, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global skin antiseptic products market size, and segment markets by type, formulation, application, and geography along with the information on companies operating in the market. The skin antiseptic products market analysis is provided for major regional markets including North America, Europe, Asia Pacific, Latin America, Middle East & Africa followed by major countries. For each region, the market size for different segments has been covered under the scope of report.
The global skin antiseptic products market is segmented as below:
Skin Antiseptic Products Market By Type
Skin Antiseptic Products Market By Formulation
Skin Antiseptic Products Market By Application
Skin Antiseptic Products Market By Geography
Major players include in this report are Sagh Products LLC, BD, Johnson & Johnson, 3 M, EcoLab, B.Braun Melsungen AG, Schulke & Mayr GmbH. and others.
The Global Next Generation Sequencing Market is expected to grow at a CAGR of around 18.7% over the forecast period 2019 to 2026 and poised to reach around US$ 20.4 Bn by 2026. Next Generation Sequencing (NGS) is a platform that enabled the sequencing of thousands to millions DNA molecules simultaneously. It is also known as the massively parallel sequencing technology. This sequencing helps in the various fie
The global ultrasound equipment market is expected to grow at a CAGR of around 6.3% from 2019 to 2026 and expected to reach the market value of around US$ 10 Bn by 2026. Ultrasound is a medical imaging technology that uses sound waves to produce pictures of body’s inside part. It helps to diagnose swelling, pain, and infection in internal organs and to examine a baby in pregnant women. Ultrasound is also
The global minimally invasive surgery market is expected to grow at a CAGR of around 9.6% over the forecast period 2019 to 2026 and expected to reach the market value of around US$ 33.8 Bn by 2026. Minimally invasive surgery uses techniques to operate with less incision or damage to the body than open surgery. Hence, it is associated with less pain, fewer postoperative complications, and short
The global implantable medical devices market is expected to grow at a CAGR of around 7.3% over the forecast period 2019 to 2026 and expected to reach the market value of around US$ 153.8 Bn by 2026. An implant is a medical device, manufactured to support or replace any damaged organs in the body, treat imperfections in normal body functions, or enhance the functioning of body organs. These can be implanted by
The Global eclinical Solutions Market is expected to grow at a CAGR of around 9.7% from 2019 to 2026 and expected to reach the market value of around US$ 9,756 Mn by 2026. The eclinical solutions refer to the development and offering of clinical technologies and expertise which are aimed at supporting the development of the clinical process. The eclinical solutions usually involve
The Global Insulin Delivery Devices Market value is expected to reach around US$ 22.5 Bn by 2026 and growing at a CAGR of around 7.2% over the forecast period 2019 to 2026. Insulin delivery devices are used to deliver insulin to patients with Type 1 and Type 2 diabetes. Insulin is an important part of treatment for the diabetes patient which helps them to get glucose from the blood